NDC 59148-238 - ABILIFY MAINTENA
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 59148-238
- Package NDCs from labels
- 59148-238-90
- Manufacturer
- Otsuka America Pharmaceutical, Inc.
- Effective date
- 2026-03-24
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| ABILIFY MAINTENA - Otsuka America Pharmaceutical, Inc. | Otsuka America Pharmaceutical, Inc. | 2026-03-24 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 59148-238-90 | ABILIFY MAINTENA | 1.9 mL in 1 VIAL, SINGLE-USE | INJECTION, SUSPENSION, EXTENDED | 1.9 mL | 400 mg in 1.9mL | 27 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| aripiprazole | ACTIVE INGREDIENT | 82VFR53I78 | ABILIFY MAINTENA (ARIPIPRAZOLE) KIT [OTSUKA AMERICA PHARMACEUTICAL, INC.] | 9 | |
| aripiprazole | ACTIVE MOIETY | 82VFR53I78 | ABILIFY MAINTENA (ARIPIPRAZOLE) KIT [OTSUKA AMERICA PHARMACEUTICAL, INC.] | 9 | |
| carboxymethylcellulose sodium | INACTIVE INGREDIENT | K679OBS311 | ABILIFY MAINTENA (ARIPIPRAZOLE) KIT [OTSUKA AMERICA PHARMACEUTICAL, INC.] | 9 | |
| mannitol | INACTIVE INGREDIENT | 3OWL53L36A | ABILIFY MAINTENA (ARIPIPRAZOLE) KIT [OTSUKA AMERICA PHARMACEUTICAL, INC.] | 9 | |
| sodium hydroxide | INACTIVE INGREDIENT | 55X04QC32I | ABILIFY MAINTENA (ARIPIPRAZOLE) KIT [OTSUKA AMERICA PHARMACEUTICAL, INC.] | 9 | |
| sodium phosphate, monobasic, monohydrate | INACTIVE INGREDIENT | 593YOG76RN | ABILIFY MAINTENA (ARIPIPRAZOLE) KIT [OTSUKA AMERICA PHARMACEUTICAL, INC.] | 9 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | ABILIFY MAINTENA (ARIPIPRAZOLE) KIT [OTSUKA AMERICA PHARMACEUTICAL, INC.] | 9 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Equate Optimal Hydration Lubricant Eye Drops | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN | Walmart, Inc. | 151b9723-5d5e-ac2b-e063-6294a90af073 | 2025-12-30 | Warnings | K679OBS311 |
| Equate Moisturizing Comfort Lubricant Eye Drops | CARBOXYMETHYLCELLULOSE SODIUM | Walmart Inc. | 152028bd-0429-720a-e063-6294a90a1465 | 2025-12-30 | Warnings | K679OBS311 |
| OCUFRESH | WATER | Optics Laboratory Inc. | b8e477a9-66b9-496b-92fb-3d4bbd7b36b5 | 2025-12-29 | Warnings | 059QF0KO0R |
| Kollourion Eyesalve Eyewash | PURIFIED WATER 98.3% | Miracle Eye Pharmaceuticals | b56d2ab9-169b-b490-e053-2a95a90a80b3 | 2025-12-28 | Warnings | 059QF0KO0R |
| Equate Lubricant Eye Drops | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN | Hanlim | 46851e7c-8910-6456-e063-6394a90abafb | 2025-12-22 | Warnings | K679OBS311 |
| Equate Lubricant Eye Drops | CARBOXYMETHYLCELLULOSE SODIUM | Hanlim | 46854996-a0b9-46b4-e063-6294a90aa433 | 2025-12-22 | Warnings | K679OBS311 |
| ARIPIPRAZOLE | ARIPIPRAZOLE | QUAGEN PHARMACEUTICALS LLC | b12f1ff2-c0b5-47e7-8075-bf2ce79fdaf8 | 2025-12-22 | Boxed warning, Warnings, Adverse reactions | 82VFR53I78 |
| Equate Lubricant Eye Drops | CARBOXYMETHYLCELLULOSE SODIUM | Walmart | 44494842-e38d-617c-e063-6294a90afaf8 | 2025-12-20 | Warnings | K679OBS311 |
| Equate Lubricant Eye Drops | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN | Walmart | 443e214b-2680-79a9-e063-6294a90a68ba | 2025-12-20 | Warnings | K679OBS311 |
| Pall Sterile Cord Blood Collection Unit | STERILE CORD BLOOD COLLECTION UNIT | Global Life Sciences Solutions USA LLC | aa9340b7-cc63-e17d-e053-2a95a90ad4d9 | 2025-12-18 | Warnings | 593YOG76RN |
| Uretron D/S | METHENAMINE, SODIUM PHOSPHATE MONOBASIC, PHENYL SALICYLATE, METHYLENE BLUE, AND HYOSCYAMINE SULFATE | DORAL PHARMAMEDICS INC dba A.G. Marin Pharmaceuticals | ea74f1aa-2b4d-4ccf-e053-2995a90abab5 | 2025-12-18 | Warnings, Adverse reactions | 593YOG76RN |
| Sterile Water | WATER | ProPharma Distribution | 386a0a2f-4ff7-f128-e063-6294a90a7d4d | 2025-12-18 | Warnings, Adverse reactions | 059QF0KO0R |
| STYE RELIEF SERUM | CARBOXYMETHYLCELLULOSE SODIUM(CMC) | Guangzhou Shimei Cosmetics Co., Ltd. | 45fa7962-b489-4613-e063-6394a90a59b0 | 2025-12-15 | Warnings | K679OBS311 |
| Gentle Eyes Lubricant Eye Drops | CARBOXYMETHYLCELLULOSE SODIUM | TRP Company | 13f99af6-b7d8-a092-e063-6394a90a5daa | 2025-12-15 | Warnings | K679OBS311 |
| Firstep Firstflush | EYEWASH | Encon Safety Products, Inc. | a44beb26-79ae-98bd-e053-2995a90a9b74 | 2025-12-09 | Warnings | 059QF0KO0R |
| Aripiprazole | ARIPIPRAZOLE | Quallent Pharmaceuticals Health LLC | 0e0d42ad-f4c6-4e30-adc2-ab1d122428ec | 2025-12-04 | Boxed warning, Warnings, Adverse reactions | 82VFR53I78 |
| Aripiprazole | ARIPIPRAZOLE | Advagen Pharma Ltd | 4537e26b-dcf8-4a78-ab7d-57359b1d2192 | 2025-12-02 | Boxed warning, Warnings, Adverse reactions | 82VFR53I78 |
| PUR-WASH | WATER | Niagara Pharmaceuticals Inc. | beda35c3-9a8b-47ad-e053-2995a90a7b1b | 2025-11-24 | Warnings | 059QF0KO0R |
| Easy Care First Aid Eyewash | WATER | Tender Corporation | a070aac8-e6d2-ef10-e053-2a95a90aa5b1 | 2025-11-24 | Warnings | 059QF0KO0R |
| PUR-WASH | WATER | Niagara Pharmaceuticals Inc. | e07a064b-f680-405c-bbcd-24fac430951e | 2025-11-24 | Warnings | 059QF0KO0R |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.